Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema

Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema

Bibliografske podrobnosti
Main Authors: Idell, S, Beckert, L, Brockway, B, Simpson, G, Southcott, A, Lee, Y, Rahman, N, Light, R, Shoemaker, S, Gillies, J, Komissarov, A, Florova, G, Sarva, K
Format: Conference item
Izdano: American Thoracic Society 2019
Opis
Izvleček:

Podobne knjige/članki